The genetics and pathology of oxidative phosphorylation

Nature Reviews Genetics

Volumn 2, Issue 5, 2001, Pages 342-352

  Smeitink, Jan ^a   Van Den Heuvel, Lambert ^a   DiMauro, Salvatore ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ARENA;

MITOCHONDRIAL DNA;

ANIMAL; CYTOLOGY; ELECTRON TRANSPORT; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL MYOPATHY; MOLECULAR BIOLOGY; MUSCLE; MUTATION; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; RECESSIVE GENE; REVIEW;

ANIMALS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; GENES, RECESSIVE; HUMANS; MITOCHONDRIAL MYOPATHIES; MOLECULAR BIOLOGY; MUSCLES; MUTATION; OXIDATIVE PHOSPHORYLATION; PHENOTYPE;

EID: 0035349906     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35072063     Document Type: Review

References (127)

1. Bourgeron, T. et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet. 11, 144-149 (1995). The first report of a nuclear OXPHOS gene mutation in complex-II-deficlent Leigh syndrome.
2. Luft, R., Ikkos, D., Palmieri, G., Ernster, L. & Afzelius, B. A. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study. J. Clin. Invest. 41, 1776-1804 (1962). The first report of a patient with a mitochondrial disorder. After this classic paper, a whole new field in human pathology was initiated.
3. Sengers, R. C., Stadhouders, A. M. & Trijbels, J. M. Mitochondrial myopathies. Clinical, morphological and biochemical aspects. Eur. J. Pediatr. 141, 192-207 (1984).
4. DiMauro, S., Bonilla, E., Davidson, M., Hirano, M. & Schon, E. A. Mitochondria in neuromuscular disorders. Biochim. Biophys. Acta 1366, 199-210 (1998).
5. Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482-1488 (1999).
6. Shoubridge, E. A. Mitochondrial encephalomyopathies. Curr. Opin. Neurol. 11, 491-496 (1998).
7. Munnich, A. et al. Clinical aspects of mitochondrial disorders. J. Inherit. Metab. Dis. 15, 448-455 (1992).
8. Hatefi, Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54, 1015-1069 (1985).
9. Saraste, M. Oxidative phosphorytation at the fin de siecle. Science 283, 1488-1493 (1999).
10. Scheffler, I. E. Mitochondria (Wiley-Liss, Inc., New York, 1999).
11. Clayton, D. A. & Vinograd, J. Circular dimer and catenate forms of mitochondrial DNA in human leukaemic leucocytes. J. Pers. 35, 652-657 (1967). This paper provided the first description of the structure of human mitochondrial DNA.
12. Barrell, B. G., Bankier, A. T. & Drouin, J. A different genetic code in human mitochondria. Nature 282, 189-194 (1979).
13. Grossmann, M. et al. Origin of tripronucleate zygotes after intracytoplasmic sperm injection. Hum. Reprod. 12, 2762-2765 (1997).
14. Hecht, N. B., Liem, H., Kleene, K. C., Distel, R. J. & Ho, S. M. Maternal inheritance of the mouse mitochondrial genome is not mediated by a loss or gross alteration of the paternal mitochondrial DNA or by methylation of the oocyte mitochondrial DNA. Dev. Biol. 102, 452-461 (1984).
15. Hecht, N. B. & Liem, H. Mitochondrial DNA is synthesized during meiosis and spermiogenesis in the mouse. Exp. Cell Res. 154, 293-293 (1984).
16. Satoh, M. & Kuroiwa, T. Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp. Cell Res. 196, 137-140 (1991).
17. Wallace, D. C., Brown, M. D. & Lott, M. T. Mitochondrial DNA variation in human evolution and disease. Gene 238, 211-230 (1999).
18. Sutovsky, P. et al. Development: ubiquitin tag for sperm mitochondria. Nature 402, 371-372 (1999).
19. St John, J. et al. Failure of elimination of paternal mitochondrial DNA in abnormal embryos. Lancet 355, 200 (2000).
20. Cummins, J. Mitochondrial DNA in mammalian reproduction. Rev. Reprod. 3, 172-182 (1998).
21. Gugneja, S., Virbasius, C. M. & Scarpulla, R. C. Nuclear respiratory factors 1 and 2 utilize similar glutamine-containing clusters of hydrophobic residues to activate transcription. Mol. Cell Biol. 16, 5708-5716 (1996).
22. Huo, L. & Scarpulla, R. C. Multiple 5′-untranslated exons in the nuclear respiratory factor 1 gene span 47 kb and contribute to transcript heterogeneity and translational efficiency. Gene 233, 213-224 (1999).
23. Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124 (1999).
24. Evans, M. J. & Scarpulla, R. C. Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences. J. Biol. Cnem. 264, 14361-14368 (1989). This paper describes important new insights into the regulatory mechanisms that are involved in the transcriptional control of OXPHOS genes.
25. Evans, M. J. & Scarpulla, R. C. NRF-1: a trans-activator of nuclear-encoded respiratory genes in animal cells. Genes Dev. 4, 1023-1034 (1990).
26. Bràidotti, G., Borthwick, I. A. & May, B. K. Identification of regulatory sequences in the gene for 5-aminolevulinate synthase from rat. J. Biol. Cnem. 268, 1109-1117 (1993).
27. Virbasius, J. V. & Scarpulla, R. C. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc. Natl Acad. Sci. USA 91, 1309-1313 (1994).
28. Shoffner, J. M. et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61, 931-937 (1990). In 1990, the first three mitochondrial DNA mutations in patients with mitochondrial disorders were described In this paper and in references 46 and 47.
29. Lehman, J. J. et al. Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106, 847-856 (2000).
30. Luis, A. M. et al. Translational regulation of mitochondrial differentiation in neonatal rat liver. Specific increase in the translational efficiency of the nuclear-encoded mitochondrial β-F1-ATPase mRNA. J. Biol. Chem. 268, 1868-1875 (1993).
31. Izquierdo, J. M. & Cuezva, J. M. Control of the translational efficiency of β-F1-ATPase mRNA depends on the regulation of a protein that binds the 3′ untranslated region of the mRNA. Mol. Cell Biol. 17, 5255-5268 (1997).
32. Di Liegro, C. M., Bellafiore, M., Izquierdo, J. M., Rantanen, A. & Cuezva, J. M. 3′-untranslated regions of oxidative phosphorylation mRNAs function in vivo as enhancers of translation. Biochem. J. 352, 109-115 (2000).
33. Grivell, L. A. et al. Mitochondrial assembly in yeast. FEBS Lett. 452, 57-60 (1999).
34. Leigh, D. Subacute necrotizing encephalomyelopathy in an infant. Biochem. J. Neurol. Neurosurg. Psychiat. 14, 216-221 (1951). This paper describes the first patient with what is now known as 'Leigh syndrome', the clinically most frequently encountered OXPHOS disorder.
35. Rahman, S. et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann. Neurol. 39, 343-351 (1996).
36. DiMauro, S., Bonilla, E. & De Vivo, D. C. Does the patient have a mitochondrial encephalomyopathy? J. Child Neurol. 14, 823-835 (1999).
37. Dalakas, M. C. et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322, 1098-1105 (1990).
38. Brinkman, K., ter Hofstede, H. J., Burger, D. M., Smeitink, J. A. & Koopmans, P. P. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12, 1735-1744 (1998).
39. Loeffen, J. L. et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum. Mutat. 15, 123-134 (2000).
40. Triepels, R. H. et al. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann. Neurol. 45, 787-790 (1999).
41. Lynn, S. et al. Mitochondrial diabetes: investigation and identification of a novel mutation. Diabetes 47, 1800-1802 (1998).
42. Chinnery, P. F. et al. The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123, 82-92 (2000).
43. Chinnery, P. F. & Turnbull, D. M. Mitochondrial DNA and disease. Lancet 354, S117-S121 (1999).
44. Leonard, J. V. & Schapira, A. H. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355, 299-304 (2000).
45. Chinnery, P. F., Howell, N., Lightowlers, R. N. & Tumbull, D. M. Genetic counseling and prenatal diagnosis for mtDNA disease. Am. J. Hum. Genet. 63, 1908-1911 (1998).
46. Goto, Y., Nonaka, I. & Horai, S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348, 651-653 (1990).
47. Holt, I. J., Harding, A. E., Petty, R. K. & Morgan-Hughes, J. A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46, 428-433 (1990).
48. Schon, E. A., Bonilla, E & DiMauro, S. Mitochondrial DNA mutations and pathogenesis. J. Bioenerg. Biomembr. 29, 131-149 (1997).
49. Jacobs, H. T. & Holt, I. J. The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't. Hum. Mol. Genet. 9, 463-465 (2000).
50. a(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopatny, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275, 4251-4257 (2000).
51. Börner, G. V. et al. Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum. Mol. Genet. 9, 467-475 (2000).
52. Chomyn, A., Enriquez, J. A., Micol, V. Fernandez-Silva, P. & Attardi, G. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacyation deficiency and concomitant reduced association of mRNA with ribosomes. J. Biol. Chem. 275, 19198-19209 (2000). This paper describes new insights in the pathophysioiogy of the mitochondrial A3243G mutation.
53. Andreu, A. L. et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N. Engl. J. Med. 341, 1037-1044 (1999).
54. Rana, M., de Coo, I., Diaz, F., Smeets, H. & Moraes, C. T. An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann. Neurol. 48, 774-781 (2000).
55. Keightley, J. A. et al. Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene. Am. J. Hum. Genet. 67, 1400-1410 (2000).
56. Wallace, D. C. et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242, 1427-1430 (1988).
57. Chinnery, P. F. et al. The mitochondrial ND6 gene is a hotspot for mutations that cause Leber's hereditary optic neuropathy. Brain 124, 209-218 (2001).
58. Parfait, B. et al. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum. Genet. 106, 236-243 (2000).
59. Baysal, B. E. Mutations in SDHD, a mitochondrial complex Il gene, in hereditary paraganglioma. Science 287, 848-851 (2000).
60. Niemann, S. & Müller, U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genet. 26, 268-270 (2000).
61. van den Heuvel, L. et al. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am. J. Hum. Genet. 62, 262-268 (1998). The first report of a nuclear gene mutation in human complex I deficiency.
62. Papa, S. et al. The NDUFS4 gene of complex I abolished cAMP-dependent activation of the complex in a child with fatal neurological syndrome. FEBS Lett. 489, 259-262 (2001).
63. Loeffen, J. et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am. J. Hum. Genet. 63, 1598-1608 (1998).
64. Schuelke, M. et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nature Genet. 21, 260-261 (1999).
65. Budde, S. M. et al. Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem. Biophys. Res. Commun. 275, 63-68 (2000).
66. Loeffen, J. et al. Mutations in the complex 1 NDUFS2 gene are associated with hypertrophie cardiomyopathy and encephalomyopathy. Ann Neurol. 49, 195-201 (2001).
67. Triepels, R. et al. Characterization of the human complex I NDUFB7 and 17.2-kDa cDNAs and mutational analysis of 19 genes of the HP fraction in complex I-deficient-patients. Hum. Genet. 106, 385-391 (2000).
68. Ahlers, P. M., Garofano, A., Kerscher, S. J. & Brandt, U. Application of the obligate aerobic yeast Yarrowia lipolytica as a eucaryotic model to analyse Leigh syndrome mutations in the complex I core subunits PSST and TYKY. Biochim. Biophys. Acta 1459, 258-265 (2000).
69. Triepels, R. et al. Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. J. Biol. Chem. 276, 8892-8897 (2001).
70. Hirano, M. et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44, 721-727 (1994).
71. Nishino, I., Spinazzola, A. & Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283, 689-692 (1999). The first description of a mutation in a gene Involved in nuclear-mitochondrial DNA communication.
72. Kaukonen, J. A. et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am. J. Hum. Genet. 58, 763-769 (1996).
73. Zeviani, M. et al. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am. J. Hum. Genet. 47, 904-914 (1990).
74. Kaukonen, J. et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289, 782-785 (2000).
75. Adams, P. L. Lightowlers, R. N. & Turnbull, D. M. Molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Ann. Neurol. 41, 268-270 (1997).
76. Zhu, Z. et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genet. 20, 337-343 (1998).
77. Tiranti, V. et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 63, 1609-1621 (1998).
78. Tiranti, V. et al. Characterization of SURF-1 expression and surf-1 p function in normal and disease conditions. Hum. Mol. Genet. 6, 2533-2540 (1999).
79. Lennard, A., Gaston, K. & Fried, M. The Surf-1 and Surf-2 genes and their essential bidirectional promoter elements are conserved between mouse and human. DM4 Cell Biol. 13, 1117-1126 (1994).
80. Yao, J. & Shoubridge, E. A. Expression and functional analysis of SURF1 in Leigh syndrome patients with cytochrome c oxidase deficiency. Hum. Mol. Genet. 8, 2541-2549 (1999).
81. Poyau, A., Buchet, K. & Godinot, C. Sequence conservation from human to prokaryotes of Surf1, a protein involved in cytochrome c oxidase assembly, deficient Leigh syndrome. FEBS Lett. 462, 416-420 (1999).
82. Papadopoulou, L. C. et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nature Genet. 23, 333-337 (1999). The first report of patients with an SCO2 complex IV assembly mutation. In a relatively short interval, mutations in other cytochrome c oxidase assembly genes were identified (references 83, 84).
83. Valnot, I. et al. A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum. Mol. Genet. 9, 1245-1249 (2000).
84. Valnot, I. et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am. J. Hum. Genet. 67, 1104-1109 (2000).
85. Rötig, A. et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia Nature Genet. 17, 215-216 (1997).
86. Di Donato, S. Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration. J. Inherit. Metab. Dis. 23, 247-263 (2000).
87. Casari, G. et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegia a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973-983 (1998).
88. DiMauro, S. & Schon, E. A. Nuclear power and mitochondrial disease. Nature Genet. 19, 214-215 (1998).
89. Koehler, C. M. et al. Human deafness dystonia syndrome is a mitochondrial disease. Cell Biol. 96, 2141-2146 (1999).
90. Delettre, C. et al. Nuclear gene OPA1, encoding a mitochondrial dynamin related protein, is mutated in dominant optic atrophy. Nature Genet. 26, 207-210 (2000).
91. Li, Y. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 11, 376-381 (1995).
92. Lebovitz, R. M. et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl Acad. Sci. USA 93, 9782-9787 (1996).
93. Graham, B. H. et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genet. 16, 226-234 (1997).
94. Wang, J. et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nature Genet 21, 133-137 (1999).
95. Li, H. et al. Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. Proc. Natl Acad. Sci. USA 97, 3467-3472 (2000).
96. Silva, J. P. et al. Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nature Genet 26, 336-340 (2000).
97. Inoue, K. et al. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nature Genet. 26, 176-181 (2000).
98. Puccio, H. et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nature Genet. 27, 181-186 (2001).
99. Larsson, N. G. et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nature Genet. 18, 231-236 (1998).
100. Murdcck, D. G., Boone, B. E., Esposito, L. A. & Wallace, D. C. Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator. J. Biol. Chem. 274, 14429-14433 (1999).
101. Kajander, O. A. et al. Human mtDNA sublimons resemble rearranged mitochondrial genomes found in pathological states. Hum. Mol. Genet. 19, 2821-2835 (2000).
102. Melov, S., Coskun, P. E. & Wallace, D. C. Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat. Res. 434, 233-242 (1999).
103. Melov, S. et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nature Genet. 18, 159-163 (1998).
104. James, A. M., Wei, Y. H., Pang, C. Y. & Murphy, M. P. Altered mitochondrial function in fibroblasts containing MELAS and MERRF mitochondrial DNA mutations. Biochem. J. 318, 401-407 (1996).
105. James, A. M., Sheard, P. W., Wei, Y. H. & Murphy, M. P. Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. Eur. J. Biochem. 259, 462-469 (1999).
106. Pitkänen, S. et al. Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complex I (NADH:dehydrogenase) of the mitochondrial respiratory chain. Pediatr. Res. 39, 513-521 (1996).
107. Pitkänen, S. & Robinson, B. H. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J. Clin. Invest. 98, 345-351 (1996).
108. Luo, X., Pitkänen, S., Kassovska-Bratinova, S., Robinson, B. H. & Lehotay, D. C. Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency. J. Clin. Invest. 99, 2877-2888 (1997).
109. Brini, M. et al. A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nature Med. 5, 951-954 (1999).
110. Anderson, S. et al. Sequence and organization of the human mitochondrial genome. Nature 290, 457-465 (1981). The first complete sequence of the human mitochondrial DNA; see reference 111 for a recent revision.
111. Andrews, R. M. et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nature Genet. 23, 147 (1999).
112. Kasamatsu, H. & Vinograd, J. Replication of circular DNA in eukaryotic cells. Annu. Rev. Biochem. 43, 695-719 (1974).
113. Aloni, Y. & Attardi, G. Symmetrical in vivo transcription of mitochondrial DNA in HeLa cells. Proc. Natl Acad. Sci. USA 68, 1757-1761 (1971).
114. Murphy, W. I., Attardi, B., Tu, C. & Artardi, G. Evidence for complete symmetrical transcription in vivo of mitochondrial DNA in HeLa cells. J. Mol. Biol. 99, 809-814 (1975)
115. Montoya, J., Christianson, T., Levons, D., Rabinowitz, M. & Attardi, G. Identification of initiation sites for heavy-strand and light-strand transcription in human mitochondrial DNA. Proc. Natl Acad. Sci. USA 79, 7195-7199 (1982).
116. Van Etten, R. A., Bird, J. W. & Clayton, D. A Identification of the 3′-ends of the two mouse mitochondrial ribosomal RNAs. The 3′-end of 16 S ribosomal RNA contains nucleotides encoded by the gene for transfer RNALeuUUR. J. Biol. Chem. 258, 10104-10110 (1983).
117. Rose, K. M., Morris, H. P. & Jacob, S. T. Mitochondrial poly(A) polymerase from a poorly differentiated hepatoma: purification and characteristics. Biochemistry 14, 1025-1032 (1975).
118. Amalric, R, Merkel, C., Gelfand, R. & Attardi, G. Fractionation of mitochondrial RNA from HeLa cells by high-resolution electrophoresis under strongly denaturing conditions. J. Mol. Biol. 118, 1-25 (1978).
119. Miller, D. L. & Martin, N. C. Characterization of the yeast mitochondrial locus necessary for tRNA biosynthesis: DNA sequence analysis and identification of a new transcript. Cell 34, 911-917 (1983).
120. Ojala, D., Montoya, J. & Attardi, G. tRNA punctuation model of RNA processing in human mitochondria. Nature 290, 470-474 (1981).
121. Dang, Y. L. & Martin, N. C. Yeast mitochondrial RNase P. Sequence of the RPM2 gene and demonstration that its product is a protein subunit of the enzyme. J. Biol. Chem. 268, 19791-19796 (1993).
122. Doersen, C. J., Guerrier-Takada, C., Altman, S. & Attardi, G. Characterization of an RNase P activity from HeLa cell mitochondria. Comparison with the cytosol RNase P activity. J. Biol. Chem. 260, 5942-5949 (1985).
123. Aprille, J. R. Mitochondrial cytopathies and mitochondrial DNA mutations. Curr. Opin. Pediatr. 3, 1045-1054 (1991).
124. Taanman, J.-W. The mitochondrial genome: structure, transcription, translation and replication. Biochim. Biophys. Acta 1410, 103-123 (1999).
125. Attardi, G. Organization and expression of the mammalian genome: a lesson in economy. Trends Biochem. Sci. March, 86-89 (1981).
126. Cuthbert, A. P. et al. Construction and characterization of a highly stable human: rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet. Cell Genet. 71, 68-76 (1995). Important new technology in the characterization of the chromosome localization responsible for disease.
127. Melov, S. et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl Acad. Sci. USA 96, 846-851 (1999).